检索结果 - Maryalice Stetler‐Stevenson

Refine Results
  1. 1
    Assessment of minimal residual disease in myeloma and the need for a consensus approach

    Assessment of minimal residual disease in myeloma and the need for a consensus approach 由 Andy C. Rawstron, Bruno Paiva, Maryalice Stetler‐Stevenson

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  2. 2
    Minimal residual disease testing in multiple myeloma by flow cytometry: major heterogeneity

    Minimal residual disease testing in multiple myeloma by flow cytometry: major heterogeneity 由 Aaron W. Flanders, Maryalice Stetler‐Stevenson, Ola Landgren

    出版 2013
    获取全文
    Carta
    加到收藏夹
    Saved in:
  3. 3
    VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy

    VH4-34+ hairy cell leukemia, a new variant with poor prognosis despite standard therapy 由 Evgeny Arons, Tara Suntum, Maryalice Stetler‐Stevenson, Robert J. Kreitman

    出版 2009
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Adult T-cell leukemia/lymphoma

    Adult T-cell leukemia/lymphoma 由 Laila Dahmoush, Yasmine M. Hijazi, Earl Barnes, Maryalice Stetler‐Stevenson, Andrea Abati

    出版 2002
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Characteristic CD103 and CD123 Expression Pattern Defines Hairy Cell Leukemia

    Characteristic CD103 and CD123 Expression Pattern Defines Hairy Cell Leukemia 由 Girish Venkataraman, Christine Aguhar, Robert J. Kreitman, Constance M. Yuan, Maryalice Stetler‐Stevenson

    出版 2011
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Bendamustine and Rituximab in Relapsed and Refractory Hairy Cell Leukemia

    Bendamustine and Rituximab in Relapsed and Refractory Hairy Cell Leukemia 由 Mauricio Burotto, Maryalice Stetler‐Stevenson, Evgeny Arons, Hong Zhou, Wyndham H. Wilson, Robert J. Kreitman

    出版 2013
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Cytotoxicity of the anti‐CD22 immunotoxin HA22 (CAT‐8015) against paediatric acute lymphoblastic leukaemia

    Cytotoxicity of the anti‐CD22 immunotoxin HA22 (CAT‐8015) against paediatric acute lymphoblastic leukaemia 由 Francis Mussai, Dario Campana, Deepa Bhojwani, Maryalice Stetler‐Stevenson, Seth M. Steinberg, Alan S. Wayne, Ira Pastan

    出版 2010
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Minimal residual disease in multiple myeloma: bringing the bench to the bedside

    Minimal residual disease in multiple myeloma: bringing the bench to the bedside 由 Sham Mailankody, Neha Korde, Alexander M. Lesokhin, Nikoletta Lendvai, Hani Hassoun, Maryalice Stetler‐Stevenson, Ola Landgren

    出版 2015
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  9. 9
    Tissue Inhibitor of Metalloproteinase-1 Alters the Tumorigenicity of Burkitt’s Lymphoma via Divergent Effects on Tumor Growth and Angiogenesis

    Tissue Inhibitor of Metalloproteinase-1 Alters the Tumorigenicity of Burkitt’s Lymphoma via Divergent Effects on Tumor Growth and Angiogenesis 由 Liliana Guédez, Andrew McMarlin, Douglas W. Kingma, Teresa Bennett, Maryalice Stetler‐Stevenson, William G. Stetler‐Stevenson

    出版 2001
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Both variant and IGHV4-34–expressing hairy cell leukemia lack the BRAF V600E mutation

    Both variant and IGHV4-34–expressing hairy cell leukemia lack the BRAF V600E mutation 由 Liqiang Xi, Evgeny Arons, Winnifred Navarro, Katherine R. Calvo, Maryalice Stetler‐Stevenson, Mark Raffeld, Robert J. Kreitman

    出版 2011
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    Coincident myelodysplastic syndrome and T‐cell large granular lymphocytic disease: clinical and pathophysiological features

    Coincident myelodysplastic syndrome and T‐cell large granular lymphocytic disease: clinical and pathophysiological features 由 Yogen Saunthararajah, Jefferey J. Molldrem, Mary Rivera, Ann Williams, Maryalice Stetler‐Stevenson, Lynn Sorbara, Neal S. Young, John Barrett

    出版 2001
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Distinguishing hairy cell leukemia variant from hairy cell leukemia: Development and validation of diagnostic criteria

    Distinguishing hairy cell leukemia variant from hairy cell leukemia: Development and validation of diagnostic criteria 由 Haipeng Shao, Katherine R. Calvo, Marlene Grönborg, Prashant Tembhare, Robert J. Kreitman, Maryalice Stetler‐Stevenson, Constance M. Yuan

    出版 2013
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease.

    A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease. 由 Michael C. Sneller, Stephen E. Straus, Elaine S. Jaffe, Jonathan S. Jaffe, Thomas A. Fleisher, Maryalice Stetler‐Stevenson, Warren Strober

    出版 1992
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    Quantification of B-cell maturation antigen, a target for novel chimeric antigen receptor T-cell therapy in Myeloma

    Quantification of B-cell maturation antigen, a target for novel chimeric antigen receptor T-cell therapy in Myeloma 由 Dalia Salem, Irina Marić, Constance M. Yuan, David J. Liewehr, David Venzon, James N. Kochenderfer, Maryalice Stetler‐Stevenson

    出版 2018
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Phase I Trial of Recombinant Immunotoxin RFB4(dsFv)-PE38 (BL22) in Patients With B-Cell Malignancies

    Phase I Trial of Recombinant Immunotoxin RFB4(dsFv)-PE38 (BL22) in Patients With B-Cell Malignancies 由 Robert J. Kreitman, David Squires, Maryalice Stetler‐Stevenson, Pierre Noël, David J. FitzGerald, Wyndham H. Wilson, Ira Pastan

    出版 2005
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    Phase II Trial of Recombinant Immunotoxin RFB4(dsFv)-PE38 (BL22) in Patients With Hairy Cell Leukemia

    Phase II Trial of Recombinant Immunotoxin RFB4(dsFv)-PE38 (BL22) in Patients With Hairy Cell Leukemia 由 Robert J. Kreitman, Maryalice Stetler‐Stevenson, Inger Margulies, Pierre Noël, David J. FitzGerald, Wyndham H. Wilson, Ira Pastan

    出版 2009
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    Efficacy of the Anti-CD22 Recombinant Immunotoxin BL22 in Chemotherapy-Resistant Hairy-Cell Leukemia

    Efficacy of the Anti-CD22 Recombinant Immunotoxin BL22 in Chemotherapy-Resistant Hairy-Cell Leukemia 由 Robert J. Kreitman, Wyndham H. Wilson, Karen Bergeron, Miranda Raggio, Maryalice Stetler‐Stevenson, David J. FitzGerald, Ira Pastan

    出版 2001
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    Characterization of CD22 expression in acute lymphoblastic leukemia

    Characterization of CD22 expression in acute lymphoblastic leukemia 由 Nirali N. Shah, Maryalice Stetler Stevenson, Constance M. Yuan, Kelly Richards, Cindy Delbrook, Robert J. Kreitman, Ira Pastan, Alan S. Wayne

    出版 2015
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    Variables affecting the quantitation of CD22 in neoplastic B cells

    Variables affecting the quantitation of CD22 in neoplastic B cells 由 Gregory A. Jasper, Indu Arun, David Venzon, Robert J. Kreitman, Alan S. Wayne, Constance M. Yuan, Gerald E. Marti, Maryalice Stetler‐Stevenson

    出版 2010
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome

    Diagnostic utility of flow cytometric immunophenotyping in myelodysplastic syndrome 由 Maryalice Stetler‐Stevenson, Diane C. Arthur, Nicholas Jabbour, Xiu Yan Xie, Jeff Molldrem, A. John Barrett, David Venzon, Margaret E. Rick

    出版 2001
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: